SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...
Infections with the hepatitis E virus often go unnoticed because they cause no symptoms. However, in patients with a weakened ...
A new study in the journal Human Gene Therapy showed that more than half of individuals with Niemann-Pick disease, type C1 ...
A new study in the peer-reviewed journal Human Gene Therapy showed that more than half of individuals with Niemann-Pick ...
A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...
Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study identifies powerful antibodies capable of neutralizing a wide range ...
A new study in the peer-reviewed journal Human Gene Therapy showed that more than half of individuals with Niemann-Pick disease, type C1 (NPC1) who were tested lacked neutralizing antibodies against ...
An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...